Events - Enabling health equality in Europe – the role of health research - 6 May 2019, Brussels, Belgium
The European Commission's Scientific Panel for Health (SPH) is a science-led expert group based on the provisions of the Horizon 2020 Specific Programme, which is tasked with helping to achieve better health and wellbeing for all.
The Panel’s main roles are to provide foresight and overall vision and strategy, as well as, to identify bottlenecks to innovation and propose solutions in the area of health and biomedical research.
Based on interactions with stakeholders during conferences and workshops, the Scientific Panel for Health set out a vision for the future of health and biomedical research in two consensus documents: ‘Better Research for Better Health’ in 2016, and a proposal ‘Building the Future of Health Research’ in 2018.
Both documents are available through the SPH website.
From further stakeholders’ consultation important topics were identified that will be the focus of the next forum to be organized with the European Commission on May 6, 2019 in Brussels: ‘Enabling health equality in Europe – the role of health research’.
The forum explores the current situation, barriers in participation and engagement with health research, and ways forward.
The SPH wishes to build an ambitious future for health research in Europe.
The forum with the European Commission is an opportunity to participate in the debate to which you are warmly invited.
For more information, please contact the SPH secretariat at SPH@p-95.com
Research Headlines - Therapeutic robots to help autistic children communicate
Health - EU researchers find link between resistance to antibiotics and sanitation
Research Headlines - Promoting gender equality in science
Research Headlines - Support for patients with respiratory diseases
Events - Forward as one: Healthcare innovation and the need for policymaker engagement - 9 April 2019, Brussels, Belgium
This year’s event is entitled "Forward as one: Healthcare Innovation and the need for policymaker engagement", and will be held in association with the Romanian Presidency of the European Union, which runs until the end of June.
More than ever before, in this crucially important year, the EAPM Conference will allow for a bridge to national representatives is order to further build on the developments that the Alliance has helped to architect in various policy areas.
It is the ideal one-stop shop, as stakeholders from every discipline and every Member State come together to forge the way ahead.
Key topics to be discussed in Brussels will include:
-
• Personalised Medicine and the Innovation Agenda: An Integrated Approach
• Technology Developments
• Hematology
• Personalised Treatments and Personalised Prevention
• Pharmaceutical/Diagnostics
• The Regulatory Framework (Part I)
• Pharmaceutical/Diagnostics
• The Regulatory Framework (Part II)
• Political Will and Institutional Support
Research Headlines - Top results from quasi-experimental 'participatory action research'
Research Headlines - Light-sensitive molecules for new disease therapies
Research Headlines - Pathways to treating chronic inflammatory diseases
Research Headlines - Personalised brain cancer treatment shows potential
Research Headlines - Gene therapy trials point to cure for rare liver disease
Research Headlines - Chromosome imaging promises breakthrough treatments
Research Headlines - Remote control of transplanted cells in Parkinson's
Research Headlines - Safe water solutions thanks to Euro-African 'cleantech' collaboration
Research Headlines - Collaboration in the clinical neurosciences
Research Headlines - Prosthetics with natural sensations for lower-limb amputees
Research Headlines - Super-resolution microscope gives better insight into cells
Events - Science Café with Vojtěch Adam - 28 February 2019, Brussels, Belgium
Vojtěch Adam is a recognized scientist in the field chemistry and biochemistry and he is an expert in the application of advanced materials in the biology. He particularly deals with metallothioneins, proteins with the ability to bind metals, with unique structure rich in cysteines.
He and his research team believe that these proteins are one of the key factors in preventing the emergence of resistance to cancer treatment with metal-based medicines. Confirmation of this fact could contribute to the more effective treatment of cancer in the future.
Prof Adam is the Vice-rector of the Mendel University in Brno and researcher at the CEITEC Brno University of Technology, Czech Republic. He holds ERC Starting Grant "Towards the Understanding a Metal-Tumour-Metabolismna" since 1 January 2018.
Science Café is a forum for discussion of current work and interesting scientific issues. It aims to be informal and accessible. Anyone can participate; speaker is there to be questioned and to talk about his work.
Research Headlines - Ageing, stem cells and a propensity to cancer
Research Headlines - New therapeutic potential for chronic inflammatory diseases
Pages
